CPRX CATALYST PHARMACEUTICALS, INC.
Last updated: May 11, 2026
Execution Consistency
Did the company actually spend money buying back stock in 3+ of the last 4 quarters?
Bought back stock in 3/4 quarters. Q3 2023: $0M, Q2 2023: $4M, Q1 2023: $3M, Q3 2021: $5M
Execution Acceleration
Is the most recent quarter's buyback spend more than 15% above the trailing average?
Latest quarter $0M vs trailing avg $4M (-100%)
Buyback vs FCF
What percentage of free cash flow is going to buybacks? Bull: 30%+. Bear: negative FCF or no buybacks.
Missing buyback or cash flow data
Buyback Intensity
How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.
Repurchased 2,549,746 shares = 4.2% of 120,879,099 outstanding (annualized)
Insider Buying
Are officers and directors buying stock with their own money on the open market?
No insider open-market purchases in the last 12 months
Insider-Buyback Convergence
Are both company buybacks and insider buying independently active? Bull when the company is buying back stock in 2+ quarters and insiders have made 2+ open-market purchases.
Need both buyback and insider purchase data
Insider Net Direction
Over the last 90 days, are insiders net buyers or net sellers on the open market?
Insiders bought $0M, sold $2M in the last 90 days (net selling)
Red Flag
Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.
Company buying back stock while insiders sold 19550313.3x more than bought. 6 C-suite officers among sellers
- Del Carmen Jeffrey (Chief Commercial Officer) sold 10,983 shares on 2025-11-26
- Elsbernd Brian (Chief Compliance/Legal Officer) sold 40,000 shares on 2025-11-12
- Elsbernd Brian (Chief Compliance/Legal Officer) sold 30,000 shares on 2025-09-08
- Elsbernd Brian (Chief Compliance/Legal Officer) sold 20,000 shares on 2025-09-03
- Elsbernd Brian (Chief Compliance/Legal Officer) sold 30,000 shares on 2025-09-04
- Miller Steve (Chief Op. & Scientific Officer) sold 115,000 shares on 2025-08-26
- Daly Richard J (President and CEO) sold 22,970 shares on 2025-08-26
- Sundaram Preethi (Chief Strategy Officer) sold 2,324 shares on 2025-06-10
- Sundaram Preethi (Chief Strategy Officer) sold 1,600 shares on 2025-06-11
- Daly Richard J (President and CEO) sold 70,000 shares on 2025-05-30